Updated Myconate Release

Plant Health Care PLC 26 September 2006 Embargoed until 7am 26 September 2006 Plant Health Care plc ('PHC' or 'the Group') Myconate - 2006 Trial Results continue to impress around the world Plant Health Care (AIM: PHC.L), a leading provider of natural products for plants and soil, is pleased to report the early success of its Myconate test programme in 2006. Building upon the impressive results from prior years, the results of this year's trials to date further validate the effectiveness of Myconate in increasing yields of many different crops all over the world. PHC's novel Myconate technology helps crops to develop larger root mass by triggering the colonisation of beneficial micro-organisms called mycorrhizal fungi. With more mycorrhizal fungi at work, each plant can draw more nutrients and moisture out of the soil. More nutrients make for healthier plants, and significantly greater overall yields. The Board believes Myconate could be the key to changing the face of farming. The safety and ease of application of Myconate means that management practices need not be over-hauled. The procedure is a straightforward blending process, either tank mixing the Myconate with the fertilizer during planting, or applying the Myconate to the seed before planting. During 2006, Myconate tests are being performed in numerous countries in the Americas and Europe, in different soil and climate conditions, with the tests conducted on many different crops and using a range of application methods. The results for four of the trials harvested so far this year are shown in the following Table. The results from all of our corn and soybean trials will be reported later. CROP: LOCATION % YIELD INCREASE COMMENTS OVER CONTROL ----------------------------------------------------------------------------- Cotton Georgia, USA 6.9 -10.4% Lint yield, 2 rates used Cotton Coahuila, Mexico 28.6% Lint yield Sorghum Tamaulipas, Mexico 47.1% Grain yield Tomatoes Provence, France 13.3% (saleable) Processing tomatoes Our trials continue to generate interest in Myconate among its target markets prior to commercial rollout. PHC is currently in discussions with several major agrichemical and seed companies concerning optimal arrangements for the commercialisation of Myconate in the principal row crops. Other strategies are being explored for the smaller acreage crops. John Brady, CEO of Plant Health Care, commented on the results, 'The current trials on cotton and tomatoes have been exceptional and further tests on a variety of different crops are underway, leading us to believe that Myconate could be more widely accepted than previously believed. 'We are very excited about the progress being made on current round of Myconate tests. These successes have put us ahead of where we expected to be and it bodes very well for the future. We expect to sign the first licensing agreement with a major agri-chemical company in 2007, one year ahead of schedule.' -ends- For further information please contact: Plant Health Care plc John Brady, CEO Tel: 001 603 525 3702 Tavistock Communications Tel: 020 7920 3150 Jeremy Carey Christian Taylor-Wilkinson Notes to Editors: About Plant Health Care Plant Health Care plc ('PHC') is a leading provider of natural products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 70 employees and has operations in the US, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC. PHC's products are aimed at the landscape, agriculture and land reclamation industries and are both environmentally beneficial and on the whole more cost effective than synthetic chemical alternatives. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Web Site: www.planthealthcare.com This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings